These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23206898)

  • 1. Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients.
    Moon SJ; Lee SH; Byun YH; Yun GY; Kim SK; Seong BL; Kim AR; Sun Park E; Kim HJ; Lee JE; Ha SK; Lee JM; Park HC
    BMC Nephrol; 2012 Dec; 13():165. PubMed ID: 23206898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
    Ott U; Sauerbrei A; Lange J; Schäfler A; Walther M; Wolf G; Wutzler P; Zell R; Krumbholz A
    Med Microbiol Immunol; 2012 Aug; 201(3):297-302. PubMed ID: 22350187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients.
    Labriola L; Hombrouck A; Maréchal C; Van Gucht S; Brochier B; Thomas I; Jadoul M; Goubau P
    Nephrol Dial Transplant; 2011 Apr; 26(4):1424-8. PubMed ID: 21273236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C; Sayan M; Sifil A; Artuk C; Yilmaz N; Bahar H; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):71-6. PubMed ID: 12745749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.
    Azevedo LS; Gerhard J; Miraglia JL; Precioso AR; Tavares Timenetsky MD; Agena F; Gamba C; Shikanai Yasuda MA; David-Neto E; Pierrotti L
    Transpl Infect Dis; 2013 Dec; 15(6):612-8. PubMed ID: 24134688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.
    Salles MJ; Sens YA; Malafronte P; Souza JF; Vilas Boas LS; Machado CM
    Transpl Infect Dis; 2012 Dec; 14(6):564-74. PubMed ID: 22882692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study.
    Broeders NE; Hombrouck A; Lemy A; Wissing KM; Racapé J; Gastaldello K; Massart A; Van Gucht S; Weichselbaum L; De Mul A; Brochier B; Thomas I; Abramowicz D
    Clin J Am Soc Nephrol; 2011 Nov; 6(11):2573-8. PubMed ID: 21921153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Lertdumrongluk P; Changsirikulchai S; Limkunakul C; Prachukthum P; Punpiput P; Buppanharun R; Chotpitayasunondh C
    Vaccine; 2012 Feb; 30(6):1108-14. PubMed ID: 22178515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand.
    Chotirosniramit N; Sugandhavesa P; Aurpibul L; Thetket S; Kosashunhanan N; Supindham T; Wongkulab P; Kaewpoowat Q; Chaiklang K; Kaewthip O; Sroysuwan P; Wongthanee A; Lerdsamran H; Puthavathana P; Suparatpinyo K
    Hum Vaccin Immunother; 2012 Dec; 8(12):1854-9. PubMed ID: 22906932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
    Nakphook S; Patumanond J; Shrestha M; Prasert K; Chittaganpitch M; Mott JA; Praphasiri P
    PLoS One; 2021; 16(6):e0253028. PubMed ID: 34106994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
    Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients.
    Son J; Lee SB; Lee DW; Kim IY; Lee SJ; Lee SM; Song SH; Seong EY; Kwak IS
    Clin Exp Nephrol; 2013 Apr; 17(2):275-83. PubMed ID: 22990301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
    Liu W; Lien YH; Lee PI; Chan TC; Wang LC; Yang CR; Ho MS; Chen JR; Ku CC; King CC
    Vaccine; 2022 May; 40(24):3402-3411. PubMed ID: 35525727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.
    Zhou Y; Ng DM; Seto WH; Ip DK; Kwok HK; Ma ES; Ng S; Lau LL; Peiris JS; Cowling BJ
    PLoS One; 2011; 6(11):e27169. PubMed ID: 22102878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine.
    Sun Y; Bian C; Xu K; Hu W; Wang T; Cui J; Wu H; Ling Z; Ji Y; Lin G; Tian L; Zhou Y; Li B; Hu G; Yu N; An W; Pan R; Zhou P; Leng Q; Huang Z; Ma X; Sun B
    PLoS One; 2010 Dec; 5(12):e14270. PubMed ID: 21151563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis: MF59-adjuvanted versus non-adjuvanted vaccines.
    Noh JY; Song JY; Choi WS; Lee J; Seo YB; Kwon YJ; Ko GJ; Cha DR; Kang YS; Lee YK; Cheong HJ; Kim WJ
    Hum Vaccin Immunother; 2016 Nov; 12(11):2902-2908. PubMed ID: 27802078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.